Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03463148 · ClinicalTrials.gov registry record
Validation of a Sensor for Non-Invasive Measurements
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 136
- Enrollment target
NCT03463148: Completed study, sponsored by Baxter Healthcare Corporation.
NCT03463148 is a clinical trial that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03463148 has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
Subjects will be measured with both a sensor and a reference device
Primary Outcome
Comparison of Blood Pressure Measurement from Sensor with Human Auscultation measurement of Blood Pressure. Specifically, Systolic Blood Pressure and Diastolic Blood Pressure with units of millimeters of mercury (mmHg) will be compared.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2017-10-24 |
| Est. Completion | 2021-04-19 |
What the finished NCT03463148 record still lists
NCT03463148 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03463148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03463148 about?
NCT03463148 is a clinical study titled "Validation of a Sensor for Non-Invasive Measurements". Subjects will be measured with both a sensor and a reference device
What is the current status of trial NCT03463148?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2017-10-24. Estimated completion is 2021-04-19.
Who is sponsoring clinical trial NCT03463148?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI